Redefining healthy aging.
*
Fifty-five years of science, united around a single purpose — supporting aesthetic outcomes across the different layers of aging skin, for individual needs.
“Healthy aging” is used as Sinclair’s corporate purpose and brand positioning. It does not describe a therapeutic effect, clinical outcome, or performance claim of any individual product.
WHO WE ARE
Sinclair is a global medical aesthetics company. We develop injectable and energy-based technologies for the many dimensions of aging skin — and we keep asking what a better solution would look like.
HOW WE WORK
Always looking for a better solution.
Better for human biology, better in the physician's hands, and better for the realities of a clinic. When the right answer doesn't exist yet, we set out to develop it.
01 · FOR HUMAN BIOLOGY
Work with the body
We begin with the clinical need and the underlying biology — not with the product we happen to have.
02 · FOR THE PHYSICIAN
Predictable in the hand
Technologies designed around how treatments are actually performed — supported by mechanism, evidence and data.
02 · FOR THE CLINIC
Made to fit practice
A portfolio that works together across patients, needs and treatment stages — built for real clinical practice.
OUR ORIGIN
Three pioneers.
One pharmaceutical foundation.
Sinclair was formed from the integration of three pioneers in aesthetics, built upon the foundation of a pharmaceutical company. We united decades of expertise across four disciplines — and pointed them all at the same problem.
01
Polymer Science
02
Multi-Energy Technologies
03
04
Bioengineering
Pharmaceutical R&D
OUR MISSION
We innovate to deliver the solution of choice for aging skin — technologies engineered for precision, personalization and performance across aesthetic treatment needs.
OUR VISION
To redefine the future of healthy aging by establishing a new standard of personalized aesthetic care — aligned with each individual's skin and soft-tissue needs.
Precision. Personalization. Performance.
*
“Healthy aging” is used as Sinclair’s corporate purpose and brand positioning. It does not describe a therapeutic effect, clinical outcome, or performance claim of any individual product.
OUR FOUNDATION
One portfolio for the many dimensions of aging skin.
7
INJECTABLE BIOMATERIALS
THE SCIENCE BEHIND US
GLOBAL REACH
2
NEUROTOXIN TECHNOLOGIES
Decades of science. Measured in proof.
The better we understand tissue response, the better we can design aesthetic technologies. Every laboratory, patent and publication contributes to our understanding of safety, performance and tissue response — and this is only the beginning.
Present in more than 55 countries.
Products and indications are subject to regulatory approval and may not be available in all markets; approved claims may vary by market.
7
ENERGY-BASED PLATFORMS
BY THE NUMBERS
8
100+
PUBLICATIONS
18
PATENT FAMILIES
GLOBAL LABS
10+
IN THE PIPELINE TO 2030
Through a direct presence in key global markets, complemented by a network of trusted distributors. Sinclair is a wholly owned subsidiary of Huadong Medicine Company Limited (Hangzhou, China) — also known as East China Pharmaceuticals, or HMC.
CAREERS